Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports

Randomized control trials (RCTs) have shown that certain intravenous iron preparations can induce high levels of fibroblast growth factor 23 (FGF‐23) and persistent hypophosphatemia. Repeated iron infusions may lead to prolonged hypophosphatemia and osteomalacia events not captured by RCTs. Several...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilaca, Tatiane, Velmurugan, Nalini, Smith, Christopher, Abrahamsen, Bo, Eastell, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322686/
https://www.ncbi.nlm.nih.gov/pubmed/35426179
http://dx.doi.org/10.1002/jbmr.4558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322686/
https://www.ncbi.nlm.nih.gov/pubmed/35426179
http://dx.doi.org/10.1002/jbmr.4558

Ejemplares similares